|
Drug type
Antiviral
Trade name
|
| bet | 14/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Drug type
|
Antiviral
|
Trade name
|
IV: Aciclovir Sandoz, DBL, Pfizer
Oral: Aciclovir GH, Aciclovir Sandoz, Acihexal, Acyclo-V, Chemmart Aciclovir, GenRx Aciclovir, Lovir, Ozvir, Pharmacor Aciclovir, Terry White Chemists Aciclovir, Zovirax
|
Presentation
|
IV: Aciclovir DBL, Pfizer: 250 mg/10 mL ampoule, 500 mg/20 mL ampoule
Aciclovir Sandoz: 250 mg, 500 mg vial (powder for reconstitution)
Oral: 200mg, 400mg, 800mg tablets (Acyclo-V, Lovir, Ozvir, Zovirax
brands are dispersible)
|
Dose
|
Treatment of HSV and VZV
IV 20 mg/kg/dose 8 hourly
Consider 12 hourly dosing in infants <30 weeks corrected age where HSV or VSV is not confirmed.
Duration of therapy (expert recommendation)
Laboratory or clinically confirmed HSV confined to skin, eye, and mouth
|
10–14 days
|
HSV encephalitis or disseminated disease
|
21 days
|
Pre-emptive therapy (high-risk asymptomatic infant without laboratory confirmed infection)
|
10 days
(expert recommendation)
|
|
|
| |
